Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-13

Clinical Trial Update: BAFF Levels and Lupus Nephritis (LN)

View source ↗

Summary

The clinical trial investigating BAFF levels in lupus nephritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universidad de Antioquia | Conditions: Lupus Nephritis | Status: WITHDRAWN